Montauk Metals Inc
MTK
Blueberries Medical Corp
BBM
Akita Drilling Ltd
AKT.B
Navco Pharmaceuticals Inc
NAV
MYND Life Sciences Inc
MYND
(Q1)2024/08/31 | (FY)2024/05/31 | (Q4)2024/05/31 | (Q3)2024/02/29 | (Q1)2023/08/31 | (FY)2023/05/31 | (Q4)2023/05/31 | (Q3)2023/02/28 | (Q2)2022/11/30 | (Q1)2022/08/31 | |
---|---|---|---|---|---|---|---|---|---|---|
营业总收入 | 0 | 0 | 48.56%-41.03万 | -89.25%2.3万 | 0 | 0 | -286.19%-79.76万 | 3.61%21.4万 | -15.02%25.39万 | -64.28%32.87万 |
营业收入 | --0 | --0 | 48.56%-41.03万 | -89.25%2.3万 | --0 | --0 | -286.19%-79.76万 | 3.61%21.4万 | -15.02%25.39万 | -64.28%32.87万 |
主营业务成本 | -87.01%2.42万 | 32.22%18.6万 | 76.23%38.27万 | -42.77%26.83万 | ||||||
毛利 | -104.10%-1,149 | -57.46%2.8万 | -257.85%-12.88万 | -86.61%6.04万 | ||||||
营业费用 | -64.70%14.67万 | -79.19%45.04万 | 21.64%-225.93万 | -81.36%38.81万 | -74.81%41.57万 | -63.41%216.37万 | -321.34%-288.33万 | 31.98%208.14万 | -16.87%130.56万 | 12.83%165.02万 |
销售和管理费用 | -64.70%14.67万 | -79.19%45.04万 | 21.49%-219.52万 | -81.65%37.71万 | -74.34%41.57万 | -62.79%216.37万 | -319.91%-279.63万 | 32.91%205.5万 | -17.19%127.54万 | 11.19%161.98万 |
-销售费用 | ---- | ---- | ---- | -57.01%6.85万 | ---- | ---- | ---- | 107.83%15.93万 | 197.34%23.53万 | 304.50%33.78万 |
-管理费用 | -64.70%14.67万 | -79.19%45.04万 | 35.16%-133.82万 | -83.72%30.86万 | -67.58%41.57万 | -59.75%216.37万 | -292.64%-206.39万 | 29.00%189.57万 | -28.81%104.01万 | -6.65%128.2万 |
折旧摊销及损耗 | ---- | ---- | ---- | -58.49%1.1万 | ---- | ---- | ---- | -14.31%2.64万 | -0.40%3.02万 | 434.61%3.04万 |
-折旧及摊销 | ---- | ---- | ---- | -58.49%1.1万 | ---- | ---- | ---- | -14.31%2.64万 | -0.40%3.02万 | 434.61%3.04万 |
营业利润 | 64.70%-14.67万 | 79.19%-45.04万 | -1.62%287.52万 | 81.04%-38.92万 | 73.85%-41.57万 | 59.78%-216.37万 | 313.62%292.27万 | -35.88%-205.34万 | 3.66%-143.45万 | -57.22%-158.98万 |
营业外利息收入与支出净额 | ||||||||||
其他净收入/费用 | -100.19%-3,256 | 1,261.32%156.57万 | 98.06%-959 | 124.94%2.08万 | 443.83%172.33万 | -102.30%-13.48万 | -102.78%-4.93万 | -118.37%-8.33万 | -78.48%50万 | -138.12%-50.12万 |
出售证券收益 | ---- | 13,742.42%154.94万 | --0 | 127.40%2.08万 | 525.56%168.7万 | -99.81%1.12万 | -103.39%-6.05万 | -116.98%-7.6万 | -76.55%54.41万 | -129.90%-39.64万 |
其他营业外收入(费用) | -108.98%-3,256 | 111.17%1.63万 | -108.59%-959 | 99.52%-35 | 134.60%3.63万 | -880.08%-14.6万 | 185.54%1.12万 | -220.66%-7,346 | -1,524.41%-4.41万 | -849.89%-10.48万 |
税前利润 | -111.47%-15万 | 148.52%111.53万 | 0.03%287.42万 | 82.76%-36.84万 | 162.54%130.76万 | -573.97%-229.85万 | 610.58%287.33万 | -102.05%-213.67万 | -211.98%-93.45万 | -788.74%-209.1万 |
所得税 | ||||||||||
除税后的权益收益 | ||||||||||
除税后利润 | -165.65%-6.73万 | 75.79%-173.24万 | 101.33%2.64万 | 82.76%-36.84万 | 104.90%10.26万 | -1,575.40%-715.48万 | -590.39%-198.3万 | -102.05%-213.67万 | -211.98%-93.45万 | -788.74%-209.1万 |
持续经营利润 | -111.47%-15万 | 148.52%111.53万 | 0.03%287.42万 | 82.76%-36.84万 | 162.54%130.76万 | -573.97%-229.85万 | 610.58%287.33万 | -102.05%-213.67万 | -211.98%-93.45万 | -788.74%-209.1万 |
停止经营利润 | 106.86%8.27万 | 41.36%-284.78万 | ---- | ---- | ---120.51万 | ---485.63万 | ---- | ---- | ---- | ---- |
归属于少数股东的净利润 | ||||||||||
归属于母公司的净利润 | -165.65%-6.73万 | 75.79%-173.24万 | 101.33%2.64万 | 82.76%-36.84万 | 104.90%10.26万 | -1,575.40%-715.48万 | -590.39%-198.3万 | -102.05%-213.67万 | -211.98%-93.45万 | -788.74%-209.1万 |
优先股派息 | ||||||||||
其他优先股派息 | ||||||||||
归属于普通股股东的净利润 | -165.65%-6.73万 | 75.79%-173.24万 | 101.33%2.64万 | 82.76%-36.84万 | 104.90%10.26万 | -1,575.40%-715.48万 | -590.39%-198.3万 | -102.05%-213.67万 | -211.98%-93.45万 | -788.74%-209.1万 |
基本每股收益 | -105.81%-0.0058 | 88.89%-0.1 | 101.33%0.0023 | 84.09%-0.0318 | 133.33%0.1 | -1,000.00%-0.9 | -504.84%-0.1714 | -100.00%-0.2 | -200.00%-0.1 | -947.24%-0.3 |
稀释每股收益 | -105.81%-0.0058 | 88.89%-0.1 | 101.33%0.0023 | 84.09%-0.0318 | 133.33%0.1 | -1,000.00%-0.9 | -504.84%-0.1714 | -100.00%-0.2 | -200.00%-0.1 | -947.24%-0.3 |
每股派息 | ||||||||||
会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
审计意见 | -- | -- | -- | -- | -- | 无保留意见 | -- | -- | -- | -- |
FY:Financial Year 年度报告,相当于上市公司向SEC披露的10-K文件。
Q:Quarter 季度报告,相当于上市公司向SEC披露的10-Q文件,其中Q1、Q2、Q3、Q4为单季报,跨度为3个月;Q6、Q9为累计季报,Q6为6个月,Q9为9个月。